High-Flow Nasal Oxygen Alone or Altering With Noninvasive Ventilation in Critically Ill Immunocompromised Patients With Acute Respiratory Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial
Lancet Respir Med 2022 Mar 21;[EPub Ahead of Print], R Coudroy, JP Frat, S Ehrmann, F Pène, M Decavèle, N Terzi, G Prat, C Garret, D Contou, A Gacouin, J Bourenne, C Girault, C Vinsonneau, J Dellamonica, G Labro, S Jochmans, A Herbland, JP Quenot, J Devaquet, D Benzekri, E Vivier, S Nseir, G Colin, D Thevenin, G Grasselli, D Bougon, M Assefi, C Guérin, T Lherm, A Kouatchet, S Ragot, AW ThilleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.